Whittier Trust CO Ligand Pharmaceuticals Inc Transaction History

Whittier Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 01, 2021	SELL	$102.33 - $144.73 $2,046 - $2,894	-20 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$89.56 - $126.72 $1,791 - $2,534	20 New	20 $2,000
Q2 2020 Jul 10, 2020	SELL	$68.28 - $123.65 $1,365 - $2,473	-20 Closed	0 $0
Q2 2018 Jul 27, 2018	BUY	$150.77 - $207.98 $3,015 - $4,159	20 New	20 $4,000
Q2 2018 Jul 20, 2018	SELL	$150.77 - $207.98 $3,015 - $4,159	-20 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$120.91 - $137.94 $2,418 - $2,758	20	20 $3,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO with notifications on news.